Evidence map›Paper›PMID 37940673›Full record

ArticleScientific reports2023

Detection of Wuchereria bancrofti in human blood samples and mosquitoes in Matayos, Busia County-Kenya.

Nancy Kinyatta, Dorcas Wachira, Rosemary Githae, Japheth Lusweti, Johnstone Ingonga, Christine Ichugu, Caroline Maina, Rukiya Haji, Francis Kimani, Rael Musili and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Nancy KinyattaKenya Medical Research Institute, Centre for Biotechnology Research and Development, P.O Box 54840-00200, Nairobi, Kenya. nkinyatta@kemri.go.ke.
Dorcas WachiraKenya Medical Research Institute, Centre for Biotechnology Research and Development, P.O Box 54840-00200, Nairobi, Kenya.
Rosemary GithaeKenya Medical Research Institute, Centre for Biotechnology Research and Development, P.O Box 54840-00200, Nairobi, Kenya.
Japheth LuswetiKenya Medical Research Institute, Centre for Biotechnology Research and Development, P.O Box 54840-00200, Nairobi, Kenya.
Johnstone IngongaKenya Medical Research Institute, Centre for Biotechnology Research and Development, P.O Box 54840-00200, Nairobi, Kenya.
Christine IchuguKenya Medical Research Institute, Centre for Biotechnology Research and Development, P.O Box 54840-00200, Nairobi, Kenya.
Caroline MainaDepartment of Bioinformatics and Molecular Biology, Jomo Kenyatta University of Agriculture and Technology, P.O Box 62000-00200, Nairobi, Kenya.
Rukiya HajiKenya Medical Research Institute, Centre for Biotechnology Research and Development, P.O Box 54840-00200, Nairobi, Kenya.
Francis KimaniKenya Medical Research Institute, Centre for Biotechnology Research and Development, P.O Box 54840-00200, Nairobi, Kenya.
Rael MusiliKenya Medical Research Institute, Centre for Biotechnology Research and Development, P.O Box 54840-00200, Nairobi, Kenya.
Jacinta MuliKenya Medical Research Institute, Centre for Biotechnology Research and Development, P.O Box 54840-00200, Nairobi, Kenya.
Luna KamauKenya Medical Research Institute, Centre for Biotechnology Research and Development, P.O Box 54840-00200, Nairobi, Kenya.
Kenya Medical Research Institute · KEJomo Kenyatta University of Agriculture and Technology · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphatic filariasis is a mosquito borne disease which leads to abnormal painful enlarged body parts, severe disability and social stigma. We screened Wuchereria bancrofti in Matayos constituency in Busia County. Blood samples were collected from 23 villages selected purposively based on clinical case reports. Finger prick and/or venous blood sampling and mosquito collections was carried out. Antigenaemia and filarial DNA prevalence were determined. Infection rates on mosquito pools were estimated and SPSS version 26 was used for descriptive statistics analysis. A total of 262 participants were recruited, 73.3% (n = 192) of the participants had no symptoms, 14.1% (n = 5.3) had swollen legs, 5.3% (n = 14) had painful legs and 3.8% (n = 10) with scrotal swellings. Average antigenemia prevalence was 35.9% (n = 94) and DNA prevalence was at 8.0% (n = 21). A total of 1305 mosquitoes were collected and pooled into 2-20 mosquitoes of the same species and from the same village. Two pools out of 78 were positive for filarial DNA with a minimum infection rate of 0.15%. From this study, antigenaemia and infected mosquitoes are an indication of active transmission. The clinical signs are evidence that filarial infections have been in circulation for over 10 years. The global climate change phenomenon currently happening has been shown to adversely affect the transmission of vector borne diseases and is likely to increase lymphatic filariasis transmission in the area. This study therefore recommends further screening before Mass Drug Administration, morbidity management and enhanced mosquito control Programmes are recommended in the study area.

Indexed as

CulexElephantiasis, FilarialAnimalsDNA, HelminthHumansKenyaWuchereria bancroftiDNA, Helminth

Identifiers

PMID37940673
PMCPMC10632445
OpenAlexW4388501253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.